Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Christina Lake CannabisCLCFF Earnings Yield (Joel Greenblatt) % is -9.70% as of Feb. 2026. The stock has 4 warning signs investors should review. Among 1,011 Drug Manufacturers companies, Christina Lake Cannabis ranks worse than 86.35% on this metric.
Christina Lake Cannabis's Enterprise Value for the quarter that ended in Feb. 2026 was $10.27 Mil.
Christina Lake Cannabis's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 was $-1.21 Mil. Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) for the quarter that ended in Feb. 2026 was -9.70%.
The historical rank and industry rank for Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
CLCFF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -37.62 Med: -10.67 Max: 73.4
Current: -12.71
During the past 8 years, the highest Earnings Yield (Joel Greenblatt) of Christina Lake Cannabis was 73.40%. The lowest was -37.62%. And the median was -10.67%.
CLCFF's Earnings Yield (Joel Greenblatt) % is ranked worse than 86.35% of 1011
companies
in the Drug Manufacturers industry
Industry Median: 3.31
vs CLCFF: -12.71
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Christina Lake Cannabis's Forward Rate of Return (Yacktman) % for the quarter that ended in Feb. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Christina Lake Cannabis (OTCPK:CLCFF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Christina Lake Cannabis Earnings Yield (Joel Greenblatt) % Related Terms
Christina Lake Cannabis Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Christina Lake Cannabis Earnings Yield (Joel Greenblatt) % Chart
CLCFF vs ZTS, UTHR: Earnings Yield (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis Earnings Yield (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's Earnings Yield (Joel Greenblatt) % falls into.
Christina Lake Cannabis Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Christina Lake Cannabiss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Feb. 2026 is calculated as
Christina Lake Cannabis's EBIT for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.21 Mil.
What does a Earnings Yield (Joel Greenblatt) % of -9.70% mean?
Christina Lake Cannabis (CLCFF) has a Earnings Yield (Joel Greenblatt) % of -9.70% as of Feb. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Christina Lake Cannabis and its competitors. According to the industry distribution chart, Christina Lake Cannabis ranks #873 out of 1011 companies in the Drug Manufacturers industry, placing it in the top 86.4%.
Is Christina Lake Cannabis' Earnings Yield (Joel Greenblatt) % too high?
Christina Lake Cannabis' current Earnings Yield (Joel Greenblatt) % is -9.70%. Based on the distribution chart, Christina Lake Cannabis ranks #873 out of 1011 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Christina Lake Cannabis' Earnings Yield (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #873 out of 1011 companies for Earnings Yield (Joel Greenblatt) %. This places Christina Lake Cannabis in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 3.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Drug Manufacturers company?
The median Earnings Yield (Joel Greenblatt) % among Drug Manufacturers companies is 3.31, based on 1,011 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median Earnings Yield (Joel Greenblatt) % is 3.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current Earnings Yield (Joel Greenblatt) % is -9.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 78.2% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is -9.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current Earnings Yield (Joel Greenblatt) % is -9.70% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCFF has been successfully added to your 
